Global Congestive Heart Failure (CHF) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147652
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs.

Scope of the Report:

This report focuses on the Congestive Heart Failure (CHF) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Congestive Heart Failure (CHF) is expected to grow at a CAGR of roughly 6.1% over the next five years, will reach 25600 million US$ in 2023, from 17900 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Abiomed

Berlin Heart

Biotronik

Boston Scientific

HeartWare

Jarvik Heart

LivaNova

Medtronic

ReliantHeart

St. Jude Medical

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

ICDs

VADs

Others

Market Segment by Applications, can be divided into

Hospital

Clinic

There are 15 Chapters to deeply display the global Congestive Heart Failure (CHF) market.

Chapter 1, to describe Congestive Heart Failure (CHF) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Congestive Heart Failure (CHF), with sales, revenue, and price of Congestive Heart Failure (CHF), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Congestive Heart Failure (CHF), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Congestive Heart Failure (CHF) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Congestive Heart Failure (CHF) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Congestive Heart Failure (CHF) Introduction

1.2 Market Analysis by Type

1.2.1 ICDs

1.2.2 VADs

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospital

1.3.2 Clinic

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Abiomed

2.1.1 Business Overview

2.1.2 Congestive Heart Failure (CHF) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abiomed Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Berlin Heart

2.2.1 Business Overview

2.2.2 Congestive Heart Failure (CHF) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Berlin Heart Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biotronik

2.3.1 Business Overview

2.3.2 Congestive Heart Failure (CHF) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biotronik Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Boston Scientific

2.4.1 Business Overview

2.4.2 Congestive Heart Failure (CHF) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Boston Scientific Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 HeartWare

2.5.1 Business Overview

2.5.2 Congestive Heart Failure (CHF) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 HeartWare Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Jarvik Heart

2.6.1 Business Overview

2.6.2 Congestive Heart Failure (CHF) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Jarvik Heart Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 LivaNova

2.7.1 Business Overview

2.7.2 Congestive Heart Failure (CHF) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 LivaNova Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Medtronic

2.8.1 Business Overview

2.8.2 Congestive Heart Failure (CHF) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Medtronic Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 ReliantHeart

2.9.1 Business Overview

2.9.2 Congestive Heart Failure (CHF) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ReliantHeart Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 St. Jude Medical

2.10.1 Business Overview

2.10.2 Congestive Heart Failure (CHF) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 St. Jude Medical Congestive Heart Failure (CHF) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Congestive Heart Failure (CHF) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Congestive Heart Failure (CHF) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Congestive Heart Failure (CHF) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Congestive Heart Failure (CHF) Manufacturer Market Share in 2017

3.3.2 Top 6 Congestive Heart Failure (CHF) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Congestive Heart Failure (CHF) Market Analysis by Regions

4.1 Global Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Regions

4.1.1 Global Congestive Heart Failure (CHF) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Congestive Heart Failure (CHF) Revenue and Market Share by Regions (2013-2018)

4.2 North America Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

4.3 Europe Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

4.5 South America Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

5 North America Congestive Heart Failure (CHF) by Countries

5.1 North America Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Countries

5.1.1 North America Congestive Heart Failure (CHF) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Congestive Heart Failure (CHF) Revenue and Market Share by Countries (2013-2018)

5.2 United States Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

5.3 Canada Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

5.4 Mexico Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

6 Europe Congestive Heart Failure (CHF) by Countries

6.1 Europe Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Countries

6.1.1 Europe Congestive Heart Failure (CHF) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Congestive Heart Failure (CHF) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

6.3 UK Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

6.4 France Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

6.5 Russia Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

6.6 Italy Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Congestive Heart Failure (CHF) by Countries

7.1 Asia-Pacific Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Congestive Heart Failure (CHF) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Congestive Heart Failure (CHF) Revenue and Market Share by Countries (2013-2018)

7.2 China Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

7.3 Japan Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

7.4 Korea Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

7.5 India Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

8 South America Congestive Heart Failure (CHF) by Countries

8.1 South America Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Countries

8.1.1 South America Congestive Heart Failure (CHF) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Congestive Heart Failure (CHF) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

8.3 Argentina Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

8.4 Colombia Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Congestive Heart Failure (CHF) by Countries

9.1 Middle East and Africa Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Congestive Heart Failure (CHF) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Congestive Heart Failure (CHF) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

9.3 UAE Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

9.4 Egypt Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

9.5 Nigeria Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

9.6 South Africa Congestive Heart Failure (CHF) Sales and Growth Rate (2013-2018)

10 Global Congestive Heart Failure (CHF) Market Segment by Type

10.1 Global Congestive Heart Failure (CHF) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Congestive Heart Failure (CHF) Sales and Market Share by Type (2013-2018)

10.1.2 Global Congestive Heart Failure (CHF) Revenue and Market Share by Type (2013-2018)

10.2 ICDs Sales Growth and Price

10.2.1 Global ICDs Sales Growth (2013-2018)

10.2.2 Global ICDs Price (2013-2018)

10.3 VADs Sales Growth and Price

10.3.1 Global VADs Sales Growth (2013-2018)

10.3.2 Global VADs Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Congestive Heart Failure (CHF) Market Segment by Application

11.1 Global Congestive Heart Failure (CHF) Sales Market Share by Application (2013-2018)

11.2 Hospital Sales Growth (2013-2018)

11.3 Clinic Sales Growth (2013-2018)

12 Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.1 Global Congestive Heart Failure (CHF) Sales, Revenue and Growth Rate (2018-2023)

12.2 Congestive Heart Failure (CHF) Market Forecast by Regions (2018-2023)

12.2.1 North America Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.2.2 Europe Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.2.4 South America Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Congestive Heart Failure (CHF) Market Forecast (2018-2023)

12.3 Congestive Heart Failure (CHF) Market Forecast by Type (2018-2023)

12.3.1 Global Congestive Heart Failure (CHF) Sales Forecast by Type (2018-2023)

12.3.2 Global Congestive Heart Failure (CHF) Market Share Forecast by Type (2018-2023)

12.4 Congestive Heart Failure (CHF) Market Forecast by Application (2018-2023)

12.4.1 Global Congestive Heart Failure (CHF) Sales Forecast by Application (2018-2023)

12.4.2 Global Congestive Heart Failure (CHF) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Congestive Heart Failure (CHF) Picture

Table Product Specifications of Congestive Heart Failure (CHF)

Figure Global Sales Market Share of Congestive Heart Failure (C

Please fill the form below, to recieve the report sample


+1